Indian Journal of Research in Homeopathy

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 12  |  Issue : 3  |  Page : 113--124

Homoeopathic treatment for lower urinary tract symptoms in men with benign prostatic hyperplasia: An open label randomised multicentric placebo-controlled clinical trial


Bindu Sharma1, Pritha Mehra2, Praveen Oberai1, Varanasi Roja1, G. R. C. Reddy3, DD Arya2, B. S. J. Raja Kumar4, PG Mohanan5, Akshaya Kumar Prusty6, Maya Padmanabhan1, Raj K Manchanda1 
1 Central Council for Research in Homoeopathy, New Delhi, India
2 Dr. D. P. Rastogi Central Research Institute (H), Noida, Uttar Pradesh, India
3 Clinical Research Unit (H), Tirupati, Andhra Pradesh, India
4 Regional Research Institute (H), Gudivada, Andhra Pradesh, India
5 National Homoeopathy Research Institute for Mental Health, Kottayam, Kerala, India
6 Clinical Research Unit (H), Port Blair, Andaman and Nicobar, India

Correspondence Address:
Dr. Pritha Mehra
Dr. D. P. Rastogi Central Research Institute (H), A 1/1, Sector 24, Noida, Uttar Pradesh
India
Dr. Varanasi Roja
Posted at Central Council for Research in Homoeopathy, (Headquarters), New Delhi
India

Objectives: The objectives of the study are to evaluate the effectiveness of Homoeopathic Constitutional remedy (HC) and Homoeopathic Constitutional + Organ remedy (HCOM) in comparison to Placebo (PL) in cases of benign prostatic hyperplasia (BPH) using International Prostate Symptom Score (IPSS), ultrasonographic changes in prostate volume, post-void residual urine, uroflowmetry and in WHO Quality of Life (QOL)-BREF. Materials and Methods: A multicentric, three-armed, randomised clinical trial was conducted at five centres. Patients were enrolled following the pre-defined inclusion and exclusion criteria, randomised into three groups in 2:2:1 ratio and were followed up for 6 months. The statistical analysis was done with modified intention-to-treat principle (mITT). Results: Out of 461 patients screened, 254 patients were enrolled in the study and 241 patients were analysed as per mITT. The mean changes in IPSS and QOL due to urinary symptoms from baseline to end of study had shown a positive trend in all the three groups. However, in HC group, the changes were more prominent as compared to the other two groups. There was no difference between HC and HCOM groups and they were equally effective in terms of managing lower urinary tract symptoms due to BPH. With regard to secondary outcome, there was no difference between the groups. The psychological, social and environmental domains of WHOQOL-BREF have shown positive trend, but there was no statistically significant difference in intervention groups. Conclusion: In this study, statistical significance was found in the IPSS in all the three groups but only in HC and not in any of the objective parameters.


How to cite this article:
Sharma B, Mehra P, Oberai P, Roja V, Reddy G, Arya D D, Raja Kumar B, Mohanan P G, Prusty AK, Padmanabhan M, Manchanda RK. Homoeopathic treatment for lower urinary tract symptoms in men with benign prostatic hyperplasia: An open label randomised multicentric placebo-controlled clinical trial.Indian J Res Homoeopathy 2018;12:113-124


How to cite this URL:
Sharma B, Mehra P, Oberai P, Roja V, Reddy G, Arya D D, Raja Kumar B, Mohanan P G, Prusty AK, Padmanabhan M, Manchanda RK. Homoeopathic treatment for lower urinary tract symptoms in men with benign prostatic hyperplasia: An open label randomised multicentric placebo-controlled clinical trial. Indian J Res Homoeopathy [serial online] 2018 [cited 2019 Jun 20 ];12:113-124
Available from: http://www.ijrh.org/article.asp?issn=0974-7168;year=2018;volume=12;issue=3;spage=113;epage=124;aulast=Sharma;type=0